scispace - formally typeset
K

Kenji Kabashima

Researcher at Kyoto University

Publications -  798
Citations -  24358

Kenji Kabashima is an academic researcher from Kyoto University. The author has contributed to research in topics: Medicine & Atopic dermatitis. The author has an hindex of 70, co-authored 686 publications receiving 18708 citations. Previous affiliations of Kenji Kabashima include Singapore Immunology Network & University of Occupational and Environmental Health Japan.

Papers
More filters
Journal ArticleDOI

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations.

TL;DR: The mechanisms of action and the limitations of anti-PD-1/PD-L1 and anti-CTLA-4 antibodies which are the two types of checkpoint inhibitors currently available to patients are examined and the future avenues of their use in melanoma and other cancers are explored.
Journal ArticleDOI

Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma†

TL;DR: Investigation of the mechanism underlining the immunosuppression of melanoma patients focused on programmed cell death‐1/PD‐1 ligand 1 (PD‐L1) interaction between tumor cells and T cells.
Journal ArticleDOI

Possible pathogenic role of Th17 cells for atopic dermatitis.

TL;DR: In this paper, the involvement of T helper cell 17 (Th17) in atopic dermatitis (AD) is investigated, and the percentage of Th17 cells was increased in peripheral blood of AD patients and associated with severity of AD.